JP2022516569A5 - - Google Patents
Info
- Publication number
- JP2022516569A5 JP2022516569A5 JP2021539410A JP2021539410A JP2022516569A5 JP 2022516569 A5 JP2022516569 A5 JP 2022516569A5 JP 2021539410 A JP2021539410 A JP 2021539410A JP 2021539410 A JP2021539410 A JP 2021539410A JP 2022516569 A5 JP2022516569 A5 JP 2022516569A5
- Authority
- JP
- Japan
- Prior art keywords
- patent document
- international
- xiaflex
- publication
- lyophilization
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024169863A JP7855655B2 (ja) | 2019-01-06 | 2024-09-30 | コラゲナーゼ製剤およびその製造方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962788916P | 2019-01-06 | 2019-01-06 | |
| US62/788,916 | 2019-01-06 | ||
| PCT/US2020/012202 WO2020142701A1 (en) | 2019-01-06 | 2020-01-03 | Collagenase formulations and methods of producing the same |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024169863A Division JP7855655B2 (ja) | 2019-01-06 | 2024-09-30 | コラゲナーゼ製剤およびその製造方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022516569A JP2022516569A (ja) | 2022-02-28 |
| JP2022516569A5 true JP2022516569A5 (cg-RX-API-DMAC10.html) | 2022-12-19 |
| JP7565280B2 JP7565280B2 (ja) | 2024-10-10 |
Family
ID=69845512
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021539410A Active JP7565280B2 (ja) | 2019-01-06 | 2020-01-03 | コラゲナーゼ製剤およびその製造方法 |
| JP2024169863A Active JP7855655B2 (ja) | 2019-01-06 | 2024-09-30 | コラゲナーゼ製剤およびその製造方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024169863A Active JP7855655B2 (ja) | 2019-01-06 | 2024-09-30 | コラゲナーゼ製剤およびその製造方法 |
Country Status (10)
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113025599B (zh) * | 2021-04-02 | 2023-09-12 | 重庆科润生物医药研发有限公司 | 一种重组溶组织梭菌i型胶原酶及其制备方法和应用 |
| CN112941058B (zh) * | 2021-04-02 | 2023-12-05 | 重庆科润生物医药研发有限公司 | 一种重组溶组织梭菌ii型胶原酶及其制备方法和应用 |
| CN114264633B (zh) * | 2022-02-10 | 2022-09-06 | 上海蓝长科技集团有限公司 | 一种福尔马肼聚合物冻干粉及制备方法 |
| CN118829726A (zh) * | 2022-03-08 | 2024-10-22 | 科纳斯特股份有限公司 | 包含胶原酶、钙、组氨酸及甘氨酸的组合物及胶原酶的稳定化方法 |
| WO2026094005A1 (en) * | 2024-11-04 | 2026-05-07 | Endo Biologics Limited | Compositions comprising collagenase for use in treatment of plantar fasciitis |
| CN119656117B (zh) * | 2024-12-18 | 2025-08-29 | 远大生命科学(鞍山)有限公司 | 一种药物组合物及其制备方法和用途 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1820516B1 (en) | 1999-02-22 | 2013-07-24 | University of Connecticut | Novel albumin-free factor VIII formulations |
| US6440414B1 (en) | 1999-10-01 | 2002-08-27 | Amgen Inc. | Pharmaceutical compositions of fibrinolytic agent |
| US20070224184A1 (en) * | 2006-02-22 | 2007-09-27 | The Research Foundation Of The State University Of New York | Method for treating cellulite |
| KR20080071192A (ko) * | 2005-11-22 | 2008-08-01 | 와이어쓰 | 면역글로불린 융합 단백질 제형 |
| US7811560B2 (en) | 2006-01-30 | 2010-10-12 | Auxilium Us Holdings, Llc | Compositions and methods for treating collagen-mediated diseases |
| EP2130551B1 (en) * | 2008-06-02 | 2012-06-06 | Roche Diagnostics GmbH | Improved purification of collagenases from clostridium histolyticum liquid culture |
| US10119131B2 (en) | 2011-03-16 | 2018-11-06 | Biospecifics Technologies Corp. | Compositions and methods for producing clostridial collagenases |
| JP2014530873A (ja) * | 2011-10-21 | 2014-11-20 | オーキシリウム インターナショナル ホールディングス，インコーポレイテッド | Ｅｆｐの治療または低減方法 |
| EP4772625A2 (en) | 2012-01-12 | 2026-07-08 | Endo Biologics Limited | Clostridium histolyticum enzyme |
| WO2014144859A1 (en) | 2013-03-15 | 2014-09-18 | Biospecifics Technologies Corporation | Treatment method and product for uterine fibroids using purified collagenase |
| US10137179B2 (en) * | 2016-05-18 | 2018-11-27 | Hyalo Technologies, LLC | Composition and method of preparation of protease microparticulate slow release preparation |
| CN110022855B (zh) * | 2016-10-07 | 2024-07-16 | 瑞泽恩制药公司 | 室温稳定的冻干蛋白质 |
| DK3589204T3 (da) * | 2017-03-01 | 2025-06-30 | Endo Operations Ltd | Apparat og fremgangsmåde til vurdering og behandling af cellulitis |
-
2020
- 2020-01-03 MX MX2021008017A patent/MX2021008017A/es unknown
- 2020-01-03 WO PCT/US2020/012202 patent/WO2020142701A1/en not_active Ceased
- 2020-01-03 AU AU2020204922A patent/AU2020204922B2/en active Active
- 2020-01-03 BR BR112021012675-9A patent/BR112021012675A2/pt active Search and Examination
- 2020-01-03 IL IL321891A patent/IL321891A/en unknown
- 2020-01-03 KR KR1020217024557A patent/KR20210113271A/ko not_active Ceased
- 2020-01-03 JP JP2021539410A patent/JP7565280B2/ja active Active
- 2020-01-03 US US17/419,899 patent/US20220305094A1/en not_active Abandoned
- 2020-01-03 KR KR1020267010947A patent/KR20260051486A/ko active Pending
- 2020-01-03 EP EP20712071.8A patent/EP3906014A1/en active Pending
- 2020-01-03 CN CN202080010875.3A patent/CN113382714A/zh active Pending
- 2020-01-03 IL IL284270A patent/IL284270B2/en unknown
-
2023
- 2023-09-29 US US18/478,368 patent/US12303557B2/en active Active
-
2024
- 2024-09-30 JP JP2024169863A patent/JP7855655B2/ja active Active
-
2025
- 2025-04-22 US US19/185,838 patent/US20250249080A1/en active Pending
- 2025-06-30 AU AU2025204915A patent/AU2025204915A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Zhang et al. | MSC exosomes alleviate temporomandibular joint osteoarthritis by attenuating inflammation and restoring matrix homeostasis | |
| Ouyang et al. | MSC-derived exosomes ameliorate erectile dysfunction by alleviation of corpus cavernosum smooth muscle apoptosis in a rat model of cavernous nerve injury | |
| JP5259710B2 (ja) | ボツリヌス毒素の安定性が改善された薬学的液状組成物 | |
| AU2008290827B2 (en) | Method for activating regulatory t-cells | |
| EA200000703A1 (ru) | Сульфонамидные производные в качестве пролекарств, ингибиторов аспартилпротеаз | |
| RU2007102698A (ru) | Композиции и способы лечения неврологических нарушений | |
| KR101899613B1 (ko) | 염증 및 혈관 증식 관련 안 질환의 치료 방법 | |
| JP2011505164A5 (cg-RX-API-DMAC10.html) | ||
| JP2018526440A (ja) | 免疫系を刺激するためのインドール化合物の使用 | |
| Zarif et al. | Stability and antiviral activity of SP40 peptide in human serum | |
| JP2020531586A (ja) | 合成リジンアナログ及び模倣物の抗ウイルス用途のための方法及び組成物 | |
| CN1625399A (zh) | 硬变肝再生的药物组合物 | |
| JP2010138143A (ja) | Ｇｌｐ−１分泌促進剤 | |
| CN1041799C (zh) | 制备血栓溶解组合物的方法 | |
| Ksander et al. | Benzofused macrocyclic lactams as triple inhibitors of endothelin-converting enzyme, neutral endopeptidase 24.11, and angiotensin-converting enzyme | |
| JP2003519088A (ja) | Ｈｉｖ感染患者の治療および予防のためのｇｓｓｇレダクターゼの使用 | |
| EP1545287A2 (en) | Vasoregulating compounds and methods of their use | |
| FR3043557A1 (fr) | Composition a action rapide d'insuline comprenant un citrate substitue | |
| US20130172397A1 (en) | Use of inhibitors of porphobilinogen deaminase in the treatment of congenital erythropoietic porphyria | |
| JP2008201683A (ja) | 食欲抑制組成物 | |
| JP2012171909A (ja) | 糖化阻害剤 | |
| Tan | SUMOylation of Viral Proteins: A Promising Host-Directed Antiviral Strategy | |
| Tauchi et al. | Inhibitory Effect of Acyl-CoA: Cholesterol Acyltransferase Inhibitor–Low Density Lipoprotein Complex on Experimental Atherosclerosis | |
| US20090286802A1 (en) | High Dose Folic Acid Compositions for Vascular Dysfunction | |
| Chan et al. | A patient with focal segmental glomerulosclerosis and acute renal failure due to crescentic membranoproliferative glomerulonephritis |